Prediabetes

Most people with CVD or risk factors have diabetes or glycemic abnormalities

Published in Drug Week, October 1st, 2004

In new research reported at the European Society of Cardiology Congress 2004, researchers sought to find out how common diabetes and, more interestingly, other glucose and insulin abnormalities (e.g., prediabetes) are in patients with different types of cardiovascular disease (CVD) or risk factors for CVD.

NAVIGATOR (Nateglinide and Valsartan in IGT Outcomes Research trial) is a massive global effort involving about 790 investigators in 40 countries.

NAVIGATOR investigators S. Priori and colleagues from the University of Pavia, Italy, screened more than 39,000 subjects with CVD/risk factors for CVD, not known to be diabetic, with a single oral...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Week

Source: Drug Week (2004-10-01)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry